Clinical Trial Update: A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DD01 in overweight/obese individuals with MASLD/MASH (NAFLD/NASH), sponsored by Neuraly, Inc.; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• DD01

Snippet

Sponsor: Neuraly, Inc. | Conditions: NAFLD, NASH | Phase 2 | Status: ACTIVE_NOT_RECRUITING